Literature DB >> 1802214

Relationship between obesity and uterine leiomyomata.

S A Shikora1, J M Niloff, B R Bistrian, R A Forse, G L Blackburn.   

Abstract

Obesity is associated with many comorbid disease states including neoplasia. The increased risk of developing endometrial cancer is thought to be due to the higher level of circulating estrogens in obese women. Uterine leiomyomata (fibroids) are also thought to be influenced by estrogens. To determine whether patients presenting with symptomatic uterine fibroids were more obese than the general population, we retrospectively reviewed the hospital records of 144 women who underwent either hysterectomy or myomectomy for uterine fibroids. Obesity was defined as preoperative weight greater than 120% of desirable body weight (DBW) for the patient's height. In our investigation, 51% of the study population were obese. Moreover, 16% were severely obese (defined as greater than 150% DBW). When compared with the general population of women in the United States matched for height and age, the study population was significantly heavier. (p less than 0.0002). Patient age, parity, menopausal status, and degree of obesity did not correlate with the number of fibroids within the uterus. Fibroid size was significantly larger in nulliparous women (p less than 0.005). These results suggest that symptomatic uterine fibroids may be another comorbid disease state associated with obesity.

Entities:  

Mesh:

Year:  1991        PMID: 1802214

Source DB:  PubMed          Journal:  Nutrition        ISSN: 0899-9007            Impact factor:   4.008


  15 in total

1.  Socioeconomic variations in hysterectomy: evidence from a linkage study of the Finnish hospital discharge register and population census.

Authors:  R Luoto; I Keskimäki; A Reunanen
Journal:  J Epidemiol Community Health       Date:  1997-02       Impact factor: 3.710

2.  Adipocytes enhance the proliferation of human leiomyoma cells via TNF-α proinflammatory cytokine.

Authors:  Sangeeta Nair; Ayman Al-Hendy
Journal:  Reprod Sci       Date:  2011-12       Impact factor: 3.060

3.  Rodent model of reproductive tract leiomyomata. Clinical and pathological features.

Authors:  J I Everitt; D C Wolf; S R Howe; T L Goldsworthy; C Walker
Journal:  Am J Pathol       Date:  1995-06       Impact factor: 4.307

Review 4.  The health disparities of uterine fibroid tumors for African American women: a public health issue.

Authors:  Heba M Eltoukhi; Monica N Modi; Meredith Weston; Alicia Y Armstrong; Elizabeth A Stewart
Journal:  Am J Obstet Gynecol       Date:  2013-08-11       Impact factor: 8.661

5.  Prevalence, symptoms and management of uterine fibroids: an international internet-based survey of 21,746 women.

Authors:  Anne Zimmermann; David Bernuit; Christoph Gerlinger; Matthias Schaefers; Katharina Geppert
Journal:  BMC Womens Health       Date:  2012-03-26       Impact factor: 2.809

Review 6.  The etiopathogenesis of uterine fibromatosis.

Authors:  L Manta; N Suciu; O Toader; R M Purcărea; A Constantin; F Popa
Journal:  J Med Life       Date:  2016 Jan-Mar

Review 7.  Etiology and pathogenesis of uterine leiomyomas: a review.

Authors:  Gordon P Flake; Janet Andersen; Darlene Dixon
Journal:  Environ Health Perspect       Date:  2003-06       Impact factor: 9.031

8.  Ayurvedic intervention in the management of uterine fibroids: A Case series.

Authors:  Kamini Dhiman
Journal:  Ayu       Date:  2014 Jul-Sep

Review 9.  Uterine fibroids: pathogenesis and interactions with endometrium and endomyometrial junction.

Authors:  Andrea Ciavattini; Jacopo Di Giuseppe; Piergiorgio Stortoni; Nina Montik; Stefano R Giannubilo; Pietro Litta; Md Soriful Islam; Andrea L Tranquilli; Fernando M Reis; Pasquapina Ciarmela
Journal:  Obstet Gynecol Int       Date:  2013-09-12

Review 10.  The Role of Complementary and Alternative Medicine for the Management of Fibroids and Associated Symptomatology.

Authors:  Nick Dalton-Brewer
Journal:  Curr Obstet Gynecol Rep       Date:  2016-04-25
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.